Epidemiology and Treatment Patterns of Paediatric PAH (Pulmonary Arterial Hypertension)

• Register: ClinicalTrials.gov
• Last refreshed on: 14 March 2016
• Main ID: NCT02576002
• Date of registration: 13/10/2015
• Prospective Registration: No
• Primary sponsor: Bayer
• Public title: Epidemiology and Treatment Patterns of Paediatric PAH (Pulmonary Arterial Hypertension)
• Scientific title: Study to Estimate the Incidence and Prevalence and Treatment Patterns of Pediatric Pulmonary Hypertension in the US
• Date of first enrolment: October 2015
• Target sample size: 2691
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT02576002
• Study type: Observational
• Study design: Observational Model: Cohort, Time Perspective: Retrospective
• Phase: N/A

Countries of recruitment

United States

Contacts

• Name: Bayer Study Director
• Affiliation: Bayer

Key inclusion & exclusion criteria

Inclusion Criteria:

- All PAH patients who were in the MarketScan database and who were under age 18 at
some time during the years 2010 through 2013

Exclusion Criteria:



Age minimum: N/A
Age maximum: 18 Years
Gender: Both

Health Condition(s) or Problem(s) studied

Hypertension, Pulmonary

Intervention(s)

Drug: Assigned pulmonary hypertension medication

Primary Outcome(s)

Incidence rate of PAH (pulmonary arterial hypertension) [Time Frame: Retrospective analysis of three year period]

Prevalence rate of PAH [Time Frame: Retrospective analysis of three year period]

Secondary Outcome(s)

Prevalence of comorbidities among PAH patients [Time Frame: Retrospective analysis of three year period]

Assigned drug treatment for PAH measured using the MarketScan database [Time Frame: Retrospective analysis of three year period]

Diagnostic procedures performed among PAH patients measured using the MarketScan database [Time Frame: Retrospective analysis of three year period]

Secondary ID(s)

18515

Source(s) of Monetary Support

Please refer to primary and secondary sponsors